Drug firm Strides Pharma Science on Saturday said its subsidiary has received approval from the US health regulator to market Ibuprofen Oral Suspension, used for the treatment of
Share this article
If you liked this article share it with your friends.they will thank you later
/newsdrum-in/media/post_banners/bPzV4OCazNnhDDM3EEZy.jpg)
2 Min read
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg){kind=logo}
